abstract |
The present invention provides a method of treating a cancer comprising an amplification of the FGFR1 gene. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or a FGFR1 ECD fusion molecule. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or a FGFR1 ECD fusion molecule in combination with at least one other therapeutic agent. |